Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusion

These findings underscore the crucial role of rhTB4 in mitigating cardiac dysfunction in an ErbB2-dependent manner. The clinical relevance of rhTB4 is demonstrated through a randomized controlled trial, emphasizing its translational potential. Further rigorous randomized studies are needed to assess the significance of early rhTB4 use post-myocardial infarction reperfusion.

Authors

Institutions

Publication Details

Journal
Cardiovascular Research
Published
2025-11-11
DOI
https://doi.org/10.1093/cvr/cvaf223
Primary Topic
Cellular Mechanics and Interactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusion

Ning Yang, Bin Yang, Chao Wu, Lei Jia et al.
Cardiovascular Research
Cellular Mechanics and Interactions
article

Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusion

Ning Yang, Bin Yang, Chao Wu, Lei Jia, Qiuting Dong, Rui Fu, Xiaohui Bian, Yuze Zhang, 正 石橋, Kefei Dou, Xinwei Jia, Dong Yin, Jincan Liu, Fan Liu, Jun Zhang, Yang Li, Jingping Wang, Chuanyu Gao, Jincheng Guo, Wenhua Lin, Jiamao Fan, Yi He, Chuan-Jue Cui, Ming Bai, Chengquan Han
article en

Abstract

These findings underscore the crucial role of rhTB4 in mitigating cardiac dysfunction in an ErbB2-dependent manner. The clinical relevance of rhTB4 is demonstrated through a randomized controlled trial, emphasizing its translational potential. Further rigorous randomized studies are needed to assess the significance of early rhTB4 use post-myocardial infarction reperfusion.

Cardiovascular ResearchVol. 121(17)
Hebei Medical University (CN), Shanxi Medical University (CN), Capital Medical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), TEDA International Cardiovascular Hospital (CN), Sinovac Biotech (CN), Xian Central Hospital (CN), Second Hospital of Hebei Medical University (CN), Beijing Luhe Hospital Affiliated to Capital Medical University (CN), Second Hospital of Shanxi Medical University (CN), Zhengzhou Central Hospital (CN), Affiliated Hospital of Hebei University (CN), Xian Yang Central Hospital (CN), Beijing Friendship Hospital (CN), Fu Wai Hospital (CN), First Hospital of Lanzhou University (CN), Shanxi Cardiovascular Hospital (CN), Lanzhou University (CN)
Openalex Percentile: Top 64%
Cellular Mechanics and Interactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.